CTS03 - COVID-19 Diagnostics

Speaker(s)

• EB

  Esther Babady, PhD

  Director, Clinical Microbiology Service
  Laboratory Medicine
  Memorial Sloan Kettering
  New York, New York

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Florian Krammer, PhD

  Professor
  Icahn School of Medicine at Mount Sinai
  New York, NY

  Disclosure: Kantaro : Other Financial or Material Support (Status: Ongoing), This is a Mount Sinai company that sells and antibody test I developed. I am not part of the company but connected via the institution. (Status: Ongoing)
• 

  Audrey Odom John, MD PhD

  Chief, Infectious Diseases
  Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania
  Philadelphia, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• discuss the use of direct virus testing during the COVID-19 pandemic
• describe the challenges in the development of the SARS-CoV-2 test
• discuss novel diagnostics for SARS-CoV-2 under development

Presentations:

• 12:00pm – 1:15pm EDT

  Challenges and current status of SARS-CoV-2 serology
  Florian Krammer, PhD – Icahn School of Medicine at Mount Sinai
• 12:00pm – 1:15pm EDT

  Direct Virus Testing
  Esther Babady, PhD – Memorial Sloan Kettering
• 12:00pm – 1:15pm EDT

  Novel COVID-19 Diagnostic Approaches
  Audrey R. Odom John, MD PhD – Children's Hospital of Philadelphia/Perelman School of Medicine, University of Pennsylvania